课题基金 / 基金详情

COMPARING EFFICACY AND TOLERABILITY OF FELODIPINE AND VERAPAMIL

COMPARING EFFICACY AND TOLERABILITY OF FELODIPINE AND VERAPAMIL
比较非洛地平和维拉帕米的疗效和耐受性
批准号：
3851802
负责人：
EDWARD C. CONRADI
金额：
$0.0万
依托单位：
MEDICAL UNIVERSITY OF SOUTH CAROLINA
依托单位国家：
美国
项目类别：
财政年份：
--
资助国家：
美国
项目状态：
未结题
起止时间：
至
来源：
https://reporter.nih.gov/project-details/3851802
关键词：
antihypertensive agents blood pressure calcium channel blockers cardiovascular disorder chemotherapy dicarboxylate dosage drug screening /evaluation human subject human therapy evaluation hypertension pyridine carboxylate vasodilators verapamil

项目摘要

项目成果

EDWARD C. CONRADI的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Of the drugs available, the calcium channel antagonists have demonstrated a favorable safety profile and efficacy in other hypertension studies. The purpose of this study is to evaluate the blood pressure lowering effect and safety of different doses of felodipine, an investigational drug, as compared to a currently marketed calcium channel antagonist, verapamil.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
DOSE RANGING AND EFFICACY OF UP 269-6 IN HYPERTENSIVE PATIENTS
DILTIAZEM ER DOSE RESPONSE IN PATIENTS WITH MILD TO MODERATE HYPERTENSION
ISRADIPINE, ENALAPRIL & ATENOLOL EFFECTS ON ELDERLY FEMALE PATIENTS
COMPARING FELODPINE AND VERAPAMIL IN UNCOMPLICATED ESSENTIAL HYPERTENSION
海外基金